PRUNE2 and posterior cortical atrophy: Another study also suggested that PCA3 appeared to be an important marker for early-stage or less invasive tumors of PCa, however, the gene expression levels of PCA3 and PRUNE2, as well as the PCA3/PRUNE2 ratio, could differentiate whether patients experience BCR events (Dias-Neto et al., 2017).